PROGRESS 2023-2 TRUST (ASX:POH) - Ann: Phosphagenics and Mylan Agree Settlement, 36995431, page-67 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

Australia's largest stock trading and investment forum Australia's #1 stock forum

POH

Click for more information

0.00%

0.0¢ progress 2023-2 trust

First 67 Last

Share
Profile

Follow
robcas

167 Posts.

4

01/01/19

11:30

Post #: 36995431
Share

Originally posted by goldenchook: ↑

Turps, still here mate. Sitting back watching. Not much for me to add. Trying hard not to get drawn into dialogue with Playez who’s strutting around continuing to do his thing. People continue to question why he does what he does, but it’s difficult as I’d love to enlighten everyone but won’t share the reasons in an online public forum. So I’ll keep quiet….for now.
In regards to the arbitration, as devastating as the result was, the process was necessary. The disappointment for me was not in Ross M and Co deciding to pursue this, but the legal representation that walks away unscathed, having been willing to run the gauntlet with what now shows to have been a poor legal case for POH.
I do wonder whether at some stage during the long process an offer of settlement was put on the table by Mylan/Strides.
In saying that people have to respect Ross & POH for coming to a relatively good outcome post result considering the strong possibility of Mylan finishing the company off.
Sure some people like to criticise Ross for ‘milking the company’. I don’t buy it. Everyone works to earn to money. That’s the pay he was offered but just because he gets paid what he gets paid doesn’t mean he isn’t doing everything in his power to try and make this work. The concept of him having a free ride is naive.
We do as a company however need something to eventuate. Whether it’s propofol, animal feed or daptomycin or what ever, we need some confirmation of commercial viability.
The FDA meeting for the patches should now have concluded. An update should be forthcoming. Can this actually go somewhere or not?
There has been many references to companies running their own due diligence on animal feeds? Can this actually go somewhere or not? If these companies don’t produce something after their own due diligence then you would expect no other would and it’s time to shelve it.
Hence we need ‘completed products’ propofol and daptomycin to produce something this year. Otherwise POH will no longer have legs or money to stand on and TPM will have run its course.

Happy new Year to all and good luck for 2019

Expand

Originally posted by goldenchook: ↑

Turps, still here mate. Sitting back watching. Not much for me to add. Trying hard not to get drawn into dialogue with Playez who’s strutting around continuing to do his thing. People continue to question why he does what he does, but it’s difficult as I’d love to enlighten everyone but won’t share the reasons in an online public forum. So I’ll keep quiet….for now.
In regards to the arbitration, as devastating as the result was, the process was necessary. The disappointment for me was not in Ross M and Co deciding to pursue this, but the legal representation that walks away unscathed, having been willing to run the gauntlet with what now shows to have been a poor legal case for POH.
I do wonder whether at some stage during the long process an offer of settlement was put on the table by Mylan/Strides.
In saying that people have to respect Ross & POH for coming to a relatively good outcome post result considering the strong possibility of Mylan finishing the company off.
Sure some people like to criticise Ross for ‘milking the company’. I don’t buy it. Everyone works to earn to money. That’s the pay he was offered but just because he gets paid what he gets paid doesn’t mean he isn’t doing everything in his power to try and make this work. The concept of him having a free ride is naive.
We do as a company however need something to eventuate. Whether it’s propofol, animal feed or daptomycin or what ever, we need some confirmation of commercial viability.
The FDA meeting for the patches should now have concluded. An update should be forthcoming. Can this actually go somewhere or not?
There has been many references to companies running their own due diligence on animal feeds? Can this actually go somewhere or not? If these companies don’t produce something after their own due diligence then you would expect no other would and it’s time to shelve it.
Hence we need ‘completed products’ propofol and daptomycin to produce something this year. Otherwise POH will no longer have legs or money to stand on and TPM will have run its course.

Happy new Year to all and good luck for 2019

Expand

Originally posted by goldenchook: ↑

Turps, still here mate. Sitting back watching. Not much for me to add. Trying hard not to get drawn into dialogue with Playez who’s strutting around continuing to do his thing. People continue to question why he does what he does, but it’s difficult as I’d love to enlighten everyone but won’t share the reasons in an online public forum. So I’ll keep quiet….for now.
In regards to the arbitration, as devastating as the result was, the process was necessary. The disappointment for me was not in Ross M and Co deciding to pursue this, but the legal representation that walks away unscathed, having been willing to run the gauntlet with what now shows to have been a poor legal case for POH.
I do wonder whether at some stage during the long process an offer of settlement was put on the table by Mylan/Strides.
In saying that people have to respect Ross & POH for coming to a relatively good outcome post result considering the strong possibility of Mylan finishing the company off.
Sure some people like to criticise Ross for ‘milking the company’. I don’t buy it. Everyone works to earn to money. That’s the pay he was offered but just because he gets paid what he gets paid doesn’t mean he isn’t doing everything in his power to try and make this work. The concept of him having a free ride is naive.
We do as a company however need something to eventuate. Whether it’s propofol, animal feed or daptomycin or what ever, we need some confirmation of commercial viability.
The FDA meeting for the patches should now have concluded. An update should be forthcoming. Can this actually go somewhere or not?
There has been many references to companies running their own due diligence on animal feeds? Can this actually go somewhere or not? If these companies don’t produce something after their own due diligence then you would expect no other would and it’s time to shelve it.
Hence we need ‘completed products’ propofol and daptomycin to produce something this year. Otherwise POH will no longer have legs or money to stand on and TPM will have run its course.

Happy new Year to all and good luck for 2019

Expand

Originally posted by goldenchook: ↑

Turps, still here mate. Sitting back watching. Not much for me to add. Trying hard not to get drawn into dialogue with Playez who’s strutting around continuing to do his thing. People continue to question why he does what he does, but it’s difficult as I’d love to enlighten everyone but won’t share the reasons in an online public forum. So I’ll keep quiet….for now.
In regards to the arbitration, as devastating as the result was, the process was necessary. The disappointment for me was not in Ross M and Co deciding to pursue this, but the legal representation that walks away unscathed, having been willing to run the gauntlet with what now shows to have been a poor legal case for POH.
I do wonder whether at some stage during the long process an offer of settlement was put on the table by Mylan/Strides.
In saying that people have to respect Ross & POH for coming to a relatively good outcome post result considering the strong possibility of Mylan finishing the company off.
Sure some people like to criticise Ross for ‘milking the company’. I don’t buy it. Everyone works to earn to money. That’s the pay he was offered but just because he gets paid what he gets paid doesn’t mean he isn’t doing everything in his power to try and make this work. The concept of him having a free ride is naive.
We do as a company however need something to eventuate. Whether it’s propofol, animal feed or daptomycin or what ever, we need some confirmation of commercial viability.
The FDA meeting for the patches should now have concluded. An update should be forthcoming. Can this actually go somewhere or not?
There has been many references to companies running their own due diligence on animal feeds? Can this actually go somewhere or not? If these companies don’t produce something after their own due diligence then you would expect no other would and it’s time to shelve it.
Hence we need ‘completed products’ propofol and daptomycin to produce something this year. Otherwise POH will no longer have legs or money to stand on and TPM will have run its course.

Happy new Year to all and good luck for 2019

Expand

POH Price at posting: 0.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 12 more messages in this thread...

First 67 Last

Add POH (ASX) to my watchlist

SPONSORED BY